Program

• Topic 1: Saving Brains, Saving Lives: Advances in Biochemical Newborn Screening
• Topic 2: From Screening to Diagnosis: Integrating Newborn Screening into Laboratory Practice
• Topic 3: Genomic Newborn Screening: Opportunities, Challenges and Implementation

• Topic 1: Step by step to validate eGFR
• Topic 2: Albuminuria: The Unseen Variability - Why Your Patient’s Risk Category Might Be Wrong
• Topic 3: New Insight from manual, automated digital microscopy and flow cytometry: Diagnostic accuracy and efficiency

• Topic 1: Transforming Routine Laboratory Data into Actionable Intelligence: A Machine Learning Algorithm for Cardiac Risk Rapid Triage
• Topic 2: The establishment of smart Laboratory platform
• Topic 3: Circulating Metabolites as Promising Plasma Biomarkers: Advancing Metabolic Syndrome Risk Assessment

• Topic 1: Smart Health, Real Impact: mHealth as a Tool for Clinical Transformation
• Topic 4: Why details matter: A comprehensive proposal on CGM standardization by the IFCC WG-CGM
• Topic 2: Transforming Non-Communicable Disorder Management Through Mobile Health: Insights from the Field
• Topic 3: Managing Data from Personal Health Devices: Recommendations from the IFCC Committee on Mobile Health and Bioengineering in Medicine

• Presentation 1
• Presentation 2
• Presentation 3
• Presentation 4

• Presentation 5
• Presentation 6
• Presentation 7
• Presentation 8

• Presentation 9
• Presentation 10
• Presentation 11
• Presentation 12

• Presentation 13
• Presentation 14
• Presentation 15
• Presentation 16

• Presentation 17
• Presentation 18
• Presentation 19
• Presentation 20

• Topic 1: The future of mass spectrometry in the clinical chemistry
• Topic 2: Introducing mass spectrometry in a resource limited setting
• Topic 3: How to make your mass spectrometry assay robust

• Topic 1: Laboratory Diagnostics and Current Challenges in Multiple Myeloma Management
• Topic 2: Standardization and Automation of Protein Electrophoresis in Clinical Practice
• Topic 3: Assessment of MRD in Multiple Myeloma using Mass Spectrometry Approaches

• Topic 1: Clinical Application of Nanopore Long-read Sequencing to Solve Diagnostic Challenges
• Topic 2: Markers for Primary Aldosteronism - More than ARR
• Topic 3: Innovative ddPCR Strategy for Newborn Screening

• Topic 1: Why NBS Training Matters: Workforce Gaps and Competency-Based Frameworks in Newborn Screening
• Topic 2: Digital Transformation in NBS Training: Virtual, Hybrid and Asynchronous Models for Scalable Capacity Building in LMIC
• Topic 3: Simulation-Based Training and High-Impact Innovations to Improve Pre-Analytical Quality in NBS

• Topic 1: Sustainability in Clinical Laboratory: From Initiatives to Actions
• Topic 2: Sustainability Diagnostics Between Making Sense and Being Sensible
• Topic 3: ESG Implementation in Laboratory Medicine: Indonesia Experience

• Topic 1: Centralization vs Decentralization of Laboratory Services: Designing the Optimal Network
• Topic 2: Standardization Across Multi-Site Laboratory Networks
• Topic 3: Maintaining Quality and Governance Across Laboratory Networks

• Topic 1: Planning a scientific study and writing it up: best practices and mistakes to avoid
• Topic 2: How to perform a good review of a scientific article submitted for publication
• Topic 3: How to plan laboratory scientific experiments: best practices and mistakes to avoid

• Topic 1: Transforming Laboratory Workflows: Artificial Intelligence for Standardization and Harmonization in Australia
• Topic 2: Global Perspectives on AI in Laboratory Medicine: Insights from the IFCC C-AILM Survey and AI implementation contest
• Topic 3: From In-House Algorithms to Clinical Deployment: Engineering Patient-Based Real-Time Quality Control Solutions

• Topic 1: DNA Methylation Biomarkers for Tumor Diagnosis
• Topic 2: Prospects of the integrated application of liquid biopsy
• Topic 3: cfDNA or gDNA? Comparing liquid biopsy and genomic DNA for MPN treatment monitoring

• Topic 1: Cardiac troponin 0/1h algorithm
• Topic 2: Cardiac troponin POC testing outside hospital
• Topic 3: Macrotroponin and troponin autoantibodies affecting cardiac troponin measurements

• Topic 1: Familial Hypercholesterolaemia in Children: Early Identification and the Importance of Family Screening
• Topic 2: Hypertriglyceridaemia in Childhood: From Common Metabolic Causes to Rare Genetic Disorders
• Topic 3: Hypocholesterolaemia in Children: When Low Cholesterol Signals Underlying Disease

• Topic 1: Roll out of global PT/INR standardization with a single Reference Measurement System supported by WHO, IFCC and SSC/ISTH
• Topic 4: Thyroid hormone standardization: critical appraisal of the current state of implementation by IVD-manufacturers
• Topic 2: Implementation of global Lipoprotein (a) standardization with the 2nd Generation, Mass Spectrometry based Reference Measurement System
• Topic 3: Update on HbA2 and HbF standardization: does it deliver what laboratorians and clinicians need?

• Topic 1: Cultivating the Next Generation of Laboratory Scientists
• Topic 4: Current Trends in AI, Robotics, and Healthcare DX in Japanese Clinical Laboratories
• Topic 2: Research by Medical Laboratory Professionals in Japanese Hospitals: Benefits and Challenges
• Topic 3: Industry-academia collaborative research and its challenges in Japanese clinical laboratory medicine

• Topic 1: AFP
• Topic 2: beta-hCG
• Topic 3: CA125
• Topic 4: CA15-3
• Topic 5: CA19-9
• Topic 6: CEA
• Topic 7: PSA

• Topic 1: Clinical and Biochemical Approach to Suspected Mitochondrial Disorders
• Topic 2: Genetic Diagnosis of Mitochondrial Diseases and Challenges in Resource-Limited Settings
• Topic 3: Case-based diagnostic approach to mitochondrial disorders in low-resource settings: Integrating clinical, biochemical and genetic insights

• Topic 1: Foundations and System Perspective
• Topic 2: Implementation Strategies and Safety Infrastructure
• Topic 3: High-Reliability Healthcare and Future Directions

• Topic 1: Web-Based Decision Support for Laboratory Testing: Translating Complex Biochemistry into Actionable Insights
• Topic 2: Interpreting Dynamic Endocrine Function Tests: A Laboratory Decision Support Approach to Test Selection and Interpretation
• Topic 3: From Measurement to Meaning: Integrating Endocrine Testing Advances into Laboratory Decision Support and Practice

• Topic 1: What analytical quality is needed for my troponin assay and how do I monitor it?
• Topic 2: What is needed from the clinical perspective?
• Topic 3: Future possibilities with troponin fragments

• Topic 1: Sampling-induced method imprecision: verifying alternative capillary sampling methods for decentralized blood collection of high-quality specimens using a novel, Six Sigma-based method
• Topic 4: Elimination of iatrogenic anemia and associated health effects: the evidence base for micro sampling, use of alternative matrices, and future directions in diagnostic technologies and patient-centered micro sampling
• Topic 2: Recent advances in micro sampling for therapeutic drug monitoring: advanced developments in dried blood spot, dried matrix spot, and volumetric absorptive micro sampling techniques, advantages and limitations
• Topic 3: Micro sampling for selective screening and detection of early mortalities from inborn errors of metabolism supports enhanced newborn screening in Malaysia

• Topic 1: From Result to Insight: Web-Based Clinical Decision Support for Aldosterone-to-Renin Ratio Interpretation
• Topic 2: Aldosterone Suppression Testing in Primary Aldosteronism: Practical Laboratory Support for Safe and Effective Implementation
• Topic 3: Adrenal Venous Sampling in Primary Aldosteronism: The Critical Role of the Laboratory in Accurate Subtyping

• Program Rose (Removing Obstacles To Cervical Screening) - Empowering Women To Eliminate Cervical Cancer
• Early Detection Of Metabolic-Dysfunction Associated Steatotic Liver Disease Using Fib-4
• Increasing awareness and improving wellness through KFRE-guided screening and management of chronic kidney disease

• Developing and Implementing Machine Learning Models in Clinical Laboratories: Best Practices and Practical Considerations
• Quality Indicators: Strategies for Achieving Sustainable Quality Excellence
• Leveraging AI for Laboratory Quality Assurance
• Laboratory Strategies for Improving IQC: IFCC Recommendations Based on ISO 15189:2022
• Implementation of Patient-Based Real-Time Quality Control (PBRTQC)
• Risk-based Quality Management in Modern Clinical Laboratories
• From Compliance to Clinical Impact: Operationalizing Risk-Based Thinking under ISO 15189:2022
• Best Practices in EQA/PT: Principle, Interpretation, Troubleshooting, and Corrective Actions
• From Data to Decisions: Building the Intelligent Laboratory in the Era of AI and Digital Health
• Integrated Case Studies: IQC, EQA, Risk management, and AI
• Interactive Panel Discussion and Q&A

• Introduction, Pre-test survey
• Quality Assurance in Point-of-Care Testing: IQC, EQA and Challenges in Quantitative and Qualitative POCT
• Method Verification and Performance Evaluation of POCT Devices
• Training and Competency Assessment of Non-Laboratory Personnel Performing POCT
• POCT Connectivity and Data Management
• POCT versus Central Laboratory Testing: Clinical Impact and Cost-Effectiveness
• Decentralizing Diagnostics: The Role of Point-of-Care Testing in Public Health Emergencies
• Interactive Case-Based Discussion: Common Pitfalls in POCT Implementation
• Panel Discussion: Establishing an Ideal Quality Management System for POCT
• Discussion of Survey results, Vote of thanks